transarterial radioembolization
Showing 1 - 25 of 358
Transarterial Radioembolization in COlorectal MEtastasis of
Not yet recruiting
- Transarterial Radioembolization
- Therasphere
- (no location specified)
Sep 7, 2023
Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))
Not yet recruiting
- Hepatocellular Carcinoma (HCC)
- Durvalumab
- +2 more
- (no location specified)
Sep 11, 2023
Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)
Not yet recruiting
- Carcinoma, Hepatocellular
- Therasphere 90Y
- Microwave Ablation
- (no location specified)
Jul 12, 2023
Hepatocellular Carcinoma Trial (Holmium-166 treatment, Holmium-166 work-up)
Not yet recruiting
- Hepatocellular Carcinoma
- Holmium-166 treatment
- Holmium-166 work-up
- (no location specified)
Jul 6, 2022
Hepatocellular Carcinoma, Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Trial in Dallas (Atezolizumab and
Not yet recruiting
- Hepatocellular Carcinoma
- Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
- Atezolizumab and bevacizumab
- transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
-
Dallas, TexasSimmons Comprehensive Cancer Center at University of Texas South
Sep 9, 2022
Biopsy After Radioembolization to Identify Changes in Tumor
Recruiting
- Colon Cancer Liver Metastasis
- +5 more
- Y90 TARE
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 30, 2022
Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)
Recruiting
- Hepatocellular Carcinoma
- +6 more
- Embolization
-
Milan, ItalyIRCCS Ospedale San Raffaele
Feb 3, 2023
Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- EYE90 Microspheres Treatment
- (no location specified)
Jul 12, 2023
Intrahepatic Cholangiocarcinoma Trial in Charleston (SIR-Spheres microspheres (Yttrium-90 Microspheres), Gemcitabine, Cisplatin)
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
- SIR-Spheres microspheres (Yttrium-90 Microspheres)
- +2 more
-
Charleston, South CarolinaMedical University of South Carolina
Nov 11, 2021
Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,
Recruiting
- Neuroendocrine Tumor Grade 2
- Neuroendocrine Tumors
- Capecitabine Oral Product
- +2 more
-
Little Rock, Arkansas
- +2 more
Aug 11, 2022
Functional Magnetic Resonance Imaging of Hepatocellular
Terminated
- Liver Neoplasm
- MRI
-
Zurich, SwitzerlandUniversity Hospital Zurich
Jan 6, 2021
Hepatocellular Carcinoma Trial in Seoul (MRI)
Recruiting
- Hepatocellular Carcinoma
- MRI
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 16, 2021
Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)
Recruiting
- Metastatic Malignant Neoplasm in the Liver
- Neuroendocrine Neoplasm
- Arterial Embolization
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 22, 2022
Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma Trial (drug, procedure, radiation, other)
Not yet recruiting
- Metastatic Cancer
- +7 more
- Standard of Care Chemotherapy
- +7 more
- (no location specified)
Apr 1, 2022
Yttrium-90 in Children, Adolescents, and Young Liver Tumors
Recruiting
- Hepatoblastoma
- +5 more
- Quality of Life Assessment
- Transarterial Radioembolization
-
Wilmington, Delaware
- +1 more
Apr 2, 2020
Hepatocellular Cancer Trial in Honolulu (Sorafenib, yttrium-90 radioembolization)
Withdrawn
- Hepatocellular Cancer
- Sorafenib
- yttrium-90 radioembolization
-
Honolulu, HawaiiUniversity of Hawaii
Nov 6, 2019
Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)
Active, not recruiting
- Hepatocellular Carcinoma
- Radioembolization using Holmium-166
-
Brussels, Anderlecht, BelgiumHôpital Universitaire Erasme, ULB
Dec 7, 2022
Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic
Not yet recruiting
- Locally Advanced Intrahepatic Cholangiocarcinoma
- +4 more
- Angiography
- +8 more
-
Jacksonville, FloridaMayo Clinic in Florida
Sep 22, 2023
Intrahepatic Cholangiocarcinoma Trial in Philadelphia (Perflutren Protein-Type A Microspheres, Contrast-Enhanced Ultrasound)
Recruiting
- Intrahepatic Cholangiocarcinoma
- Perflutren Protein-Type A Microspheres
- Contrast-Enhanced Ultrasound
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Apr 7, 2022
Hepatocellular Carcinoma Trial in Seoul (Durvalumab, Radioembolization)
Active, not recruiting
- Hepatocellular Carcinoma
- Durvalumab
- Radioembolization
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 23, 2021
HCC Trial in Bologna (Personalized dosimetry approach, Standard dosimetry approach)
Recruiting
- HCC
- Personalized dosimetry approach
- Standard dosimetry approach
-
Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna
Jan 26, 2022
Intrahepatic Cholangiocarcinoma Trial in Fairfax (Induction Chemotherapy Triplet Therapy, Concurrent Y-90 treatment,
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Induction Chemotherapy Triplet Therapy
- +2 more
-
Fairfax, VirginiaInova Schar Cancer Institute
Jun 14, 2022
Hypoxia Before Radioembolization Treatment With 18F-FMISO PET
Recruiting
- Radioembolization
- +3 more
- 18F-Fluoromisonidazole PET
-
Ankara, TurkeyAnkara University
Sep 7, 2023